TVARDI THERAPEUTICS, INC. Operating Cash Flow
TVARDI THERAPEUTICS, INC. (TVRD) reported Operating Cash Flow of -$15.09 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-14
- TVARDI THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$9.23M.
- TVARDI THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$5.86M.
- TVARDI THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$5.68M.
- TVARDI THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$4.26M.
- TVARDI THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$23.50M.
- TVARDI THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$18.30M.
- TVARDI THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$92.08M.
- TVARDI THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$78.73M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$9.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$15.09M 10-Q · filed 2026-08-14 | -$20.77M derived: sum of 3 quarters · filed 2026-08-14 | -$25.03M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | -$5.86M 10-Q · filed 2026-05-08 | -$11.54M derived: sum of 2 quarters · filed 2026-05-08 | -$15.80M derived: sum of 3 quarters · filed 2026-05-08 | -$21.67M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | -$5.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$9.94M derived: sum of 2 quarters · filed 2026-03-31 | -$15.81M derived: sum of 3 quarters · filed 2026-08-14 | -$23.50M 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | -$4.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$10.13M derived: sum of 2 quarters · filed 2026-08-14 | -$17.81M 10-Q · filed 2025-11-13 | -$22.65M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | -$5.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$13.56M 10-Q · filed 2026-08-14 | -$18.39M derived: sum of 3 quarters · filed 2026-08-14 | -$25.05M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | -$7.69M 10-Q · filed 2026-05-08 | -$4.69M 10-Q · filed 2025-05-13 | -$12.52M derived: sum of 2 quarters · filed 2026-05-08 | -$19.18M derived: sum of 3 quarters · filed 2026-05-08 | $4.46M derived: sum of 4 quarters · filed 2026-05-08 | |||
| 2024-12-31 | -$4.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$11.49M derived: sum of 2 quarters · filed 2026-03-31 | $12.15M derived: sum of 3 quarters · filed 2026-03-31 | -$18.30M 10-K · filed 2026-03-31 | -$60.92M 10-K · filed 2025-03-11 | |||
| 2024-09-30 | -$6.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $16.98M derived: sum of 2 quarters · filed 2025-11-13 | -$13.47M 10-Q · filed 2025-11-13 | -$56.87M 10-Q · filed 2024-11-14 | -$30.84M derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | $23.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$6.82M 10-Q · filed 2025-08-14 | -$42.89M 10-Q · filed 2024-08-14 | -$24.19M derived: sum of 3 quarters · filed 2025-08-14 | -$43.83M derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | -$30.45M 10-Q · filed 2025-05-13 | -$47.82M derived: sum of 2 quarters · filed 2025-05-13 | -$67.47M derived: sum of 3 quarters · filed 2025-05-13 | -$87.91M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | -$17.37M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$37.02M derived: sum of 2 quarters · filed 2025-03-11 | -$57.46M derived: sum of 3 quarters · filed 2025-03-11 | -$92.08M 10-K · filed 2025-03-11 | ||||
| 2023-09-30 | -$19.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$40.09M derived: sum of 2 quarters · filed 2024-11-14 | -$74.71M 10-Q · filed 2024-11-14 | -$98.22M derived: sum of 4 quarters · filed 2025-03-11 | ||||
| 2023-06-30 | -$20.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$55.06M 10-Q · filed 2024-08-14 | -$78.57M derived: sum of 3 quarters · filed 2025-03-11 | -$103.77M derived: sum of 4 quarters · filed 2025-03-11 | ||||
| 2023-03-31 | -$34.62M 10-Q · filed 2024-05-13 | -$58.13M derived: sum of 2 quarters · filed 2025-03-11 | -$83.32M derived: sum of 3 quarters · filed 2025-03-11 | -$87.82M derived: sum of 4 quarters · filed 2025-03-11 | ||||
| 2022-12-31 | -$23.51M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$48.70M derived: sum of 2 quarters · filed 2025-03-11 | -$53.20M derived: sum of 3 quarters · filed 2025-03-11 | -$78.73M 10-K · filed 2025-03-11 | ||||
| 2022-09-30 | -$25.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$29.70M derived: sum of 2 quarters · filed 2023-11-13 | -$55.22M 10-Q · filed 2023-11-13 | -$56.47M derived: sum of 4 quarters · filed 2024-03-06 | ||||
| 2022-06-30 | -$4.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$30.03M 10-Q · filed 2023-08-07 | -$31.27M derived: sum of 3 quarters · filed 2024-03-06 | -$45.39M derived: sum of 4 quarters · filed 2024-03-06 | ||||
| 2022-03-31 | -$25.52M 10-Q · filed 2023-05-15 | -$26.77M derived: sum of 2 quarters · filed 2024-03-06 | -$40.89M derived: sum of 3 quarters · filed 2024-03-06 | -$61.89M derived: sum of 4 quarters · filed 2024-03-06 | ||||
| 2021-12-31 | -$1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | -$15.36M derived: sum of 2 quarters · filed 2024-03-06 | -$36.37M derived: sum of 3 quarters · filed 2024-03-06 | -$60.09M 10-K · filed 2024-03-06 | ||||
| 2021-09-30 | -$14.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$35.12M derived: sum of 2 quarters · filed 2022-11-07 | -$58.84M 10-Q · filed 2022-11-07 | $23.25M derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2021-06-30 | -$21.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$44.73M 10-Q · filed 2022-08-08 | $37.36M derived: sum of 3 quarters · filed 2023-03-06 | $15.74M derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2021-03-31 | -$23.72M 10-Q · filed 2022-05-09 | $58.37M derived: sum of 2 quarters · filed 2023-03-06 | $36.75M derived: sum of 3 quarters · filed 2023-03-06 | $9.10M derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2020-12-31 | $82.09M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $60.47M derived: sum of 2 quarters · filed 2023-03-06 | $32.82M derived: sum of 3 quarters · filed 2023-03-06 | -$5.49M 10-K · filed 2023-03-06 | ||||
| 2020-09-30 | -$21.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$49.27M derived: sum of 2 quarters · filed 2021-11-08 | -$87.58M 10-Q · filed 2021-11-08 | -$118.74M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | -$27.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$65.95M 10-Q · filed 2021-08-09 | -$97.12M derived: sum of 3 quarters · filed 2022-03-01 | -$122.76M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | -$38.30M 10-Q · filed 2021-05-10 | -$69.47M derived: sum of 2 quarters · filed 2022-03-01 | -$95.11M derived: sum of 3 quarters · filed 2022-03-01 | -$120.00M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | -$31.17M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$56.80M derived: sum of 2 quarters · filed 2022-03-01 | -$81.70M derived: sum of 3 quarters · filed 2022-03-01 | -$109.22M 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | -$25.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$50.53M derived: sum of 2 quarters · filed 2020-11-09 | -$78.06M 10-Q · filed 2020-11-09 | -$102.42M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | -$24.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$52.42M 10-Q · filed 2020-08-10 | -$76.78M derived: sum of 3 quarters · filed 2021-02-25 | -$97.28M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | -$27.53M 10-Q · filed 2020-05-11 | -$51.89M derived: sum of 2 quarters · filed 2021-02-25 | -$72.38M derived: sum of 3 quarters · filed 2021-02-25 | -$31.36M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | -$24.36M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$44.85M derived: sum of 2 quarters · filed 2021-02-25 | -$3.83M derived: sum of 3 quarters · filed 2021-02-25 | -$22.30M 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | -$20.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $20.53M derived: sum of 2 quarters · filed 2019-11-05 | $2.06M 10-Q · filed 2019-11-05 | -$9.35M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-06-30 | $41.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $22.55M 10-Q · filed 2019-08-07 | $11.14M derived: sum of 3 quarters · filed 2020-02-27 | $1.29M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | -$18.47M 10-Q · filed 2019-05-07 | -$29.88M derived: sum of 2 quarters · filed 2020-02-27 | -$39.73M derived: sum of 3 quarters · filed 2020-02-27 | |||||
| 2017-12-31 | -$11.41M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$21.26M derived: sum of 2 quarters · filed 2020-02-27 | -$54.83M 10-K · filed 2020-02-27 | |||||
| 2017-09-30 | -$9.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$43.41M 10-Q · filed 2018-11-06 | ||||||
| 2017-06-30 | -$33.56M 10-Q · filed 2018-08-07 | |||||||
| 2016-12-31 | -$47.38M 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |